Definitive Healthcare Corp. Class A Common Stock (DH) Technical Analysis
$0.98
Insights
- Definitive Healthcare Corp. Class A is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Definitive Healthcare Corp. Class A stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Definitive Healthcare Corp. Class A stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Definitive Healthcare Corp. Class A stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 61.37 | Sell |
Stochastic | 75.29, 47.62 | Neutral |
Ultimate Oscillator | 54.37 | Neutral |
Stochastic Relative Strength Index | 31.68, 15.97 | Neutral |
Moving Average Convergence Divergence | 0.05, 0.06 | Sell |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.98 | Buy |
20 | 0.97 | Buy |
50 | 0.81 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.97 | Buy |
20 | 0.94 | Buy |
50 | 0.87 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.95 | Neutral |
20 | 1.01 | Neutral |
50 | 0.95 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.98 | Sell |
20 | 1.01 | Buy |
50 | 0.92 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.97 | Sell |
20 | 1.01 | Buy |
50 | 1.0 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 1.17 |
Resistance L2 | 1.09 |
Resistance L1 | 1.05 |
Pivot Point | 0.97 |
Support L1 | 0.93 |
Support L2 | 0.85 |
Support L3 | 0.81 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.